Cronos Group Inc (NASDAQ: CRON) stock surged 19.07% on October 15^th, 2018 and also soared over 8.3% in the pre market session on October 16^th, 2018 (as of 7:51 AM GMT-4 ; Source: Google finance). The firm entered into a partnership with a technology institute in Israel, under which researchers will look at the potential use of cannabinoids in support of skin health and to fight skin disorders such as acne and psoriasis. The agreement was reached with Technion Research and Development Foundation, which is a subsidiary of the Technion – Israel Institute of Technology. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair. The research will utilize Dr Meiri’s cannabis strain database of over 80 cultivars and Cronos Group’s strain specific cannabis oils to isolate and investigate the effects of individual and combinations of cannabinoids, potentially including rare cannabinoids, for treating acne, psoriasis and wounds using stem cell-derived organoid cultures developed by Dr Fuchs’ laboratory and mouse models.  Cronos Group expects to be able to adapt the individual and combinations of cannabinoids to develop products for each of these three applications and expects to receive an exclusive, worldwide license to market and manufacture such products.

Further, the company going to benefit from Wednesday’s effective date for legal sales of recreational cannabis product in Canada. Marijuana investors have looked forward to Oct. 17 for a long time, and expectation that the industry will bring in huge amounts of revenue from the Great White North. Cannabis legalization is sweeping over North America, 10 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization comes to Canada in October 2018. And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.

On the other hand, Aleafia Health Inc. and Cronos Group Inc. have commenced a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness. The study is funded in part by Peace Naturals Project Inc., a licensed producer of medical cannabis that is wholly owned by Cronos Group. The study will be led by physicians practicing within the Canabo Medical Clinic network, which is wholly owned by Aleafia. The study will aim to assist in the treatment of insomnia and the development of non-addictive, natural sleep aids. Overall, the negative health impacts of sleep disorders and their proper treatment must be more widely acknowledged and understood.